191 DETECT III – a Multicenter, Randomized, Phase III Study to Compare Standard Therapy Alone Versus Standard Therapy Plus Lapatinib in Patients with Initially HER2-negative Metastatic Breast Cancer and HER2-positive Circulating Tumor Cells

✍ Scribed by C.A. Melcher; W. Janni; B. Rack; V. Muller; A. Schneeweiss; K. Pantel; E.F. Solomayer; B. Aktas; P. Fasching; T. Fehm

• Book ID: 117662102
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 78 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(12)70259-9